Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I M Spitz

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Steroids|February 24, 2001
The bible: truth or legend, fact or fantasy?I M Spitz
Clinical Obstetrics and Gynecology|June 1, 1996
Mifepristone: clinical pharmacologyA Robbins, I M Spitz
Israel Journal of Medical Sciences|October 1, 1975
Isolated gonadotropin deficiency and related disordersD Rabinowitz, I M Spitz
Human Reproduction Update|February 23, 1999
Mechanism of action and clinical effects of antiprogestins on the non-pregnant uterusI M Spitz, A Robbins
Steroids|December 8, 2000
Progesterone receptor modulators and progesterone antagonists in women's healthI M Spitz, K Chwalisz
Clinical Obstetrics and Gynecology|June 1, 1989
Progesterone antagonists on the horizonI M Spitz, C W Bardin
Contraception|November 1, 1993
Clinical pharmacology of RU 486--an antiprogestin and antiglucocorticoidI M Spitz, C W Bardin
American Journal of Obstetrics and Gynecology|December 22, 1999
Use of various ultrasonographic criteria to evaluate the efficacy of mifepristone and misoprostol for medical abortionM D Creinin, I M Spitz
The New England Journal of Medicine|August 5, 1993
Mifepristone (RU 486)--a modulator of progestin and glucocorticoid actionI M Spitz, C W Bardin
Family Planning Perspectives|November 1, 1985
Antiprogestins: prospects for a once-a-month pillI M Spitz, C W Bardin
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Steroids|February 24, 2001
The bible: truth or legend, fact or fantasy?I M Spitz
Clinical Obstetrics and Gynecology|June 1, 1996
Mifepristone: clinical pharmacologyA Robbins, I M Spitz
Israel Journal of Medical Sciences|October 1, 1975
Isolated gonadotropin deficiency and related disordersD Rabinowitz, I M Spitz
Human Reproduction Update|February 23, 1999
Mechanism of action and clinical effects of antiprogestins on the non-pregnant uterusI M Spitz, A Robbins
Steroids|December 8, 2000
Progesterone receptor modulators and progesterone antagonists in women's healthI M Spitz, K Chwalisz
Clinical Obstetrics and Gynecology|June 1, 1989
Progesterone antagonists on the horizonI M Spitz, C W Bardin
Contraception|November 1, 1993
Clinical pharmacology of RU 486--an antiprogestin and antiglucocorticoidI M Spitz, C W Bardin
American Journal of Obstetrics and Gynecology|December 22, 1999
Use of various ultrasonographic criteria to evaluate the efficacy of mifepristone and misoprostol for medical abortionM D Creinin, I M Spitz
The New England Journal of Medicine|August 5, 1993
Mifepristone (RU 486)--a modulator of progestin and glucocorticoid actionI M Spitz, C W Bardin
Family Planning Perspectives|November 1, 1985
Antiprogestins: prospects for a once-a-month pillI M Spitz, C W Bardin
Pageof 13